Literature DB >> 21732699

Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.

Tsutomu Shimada1, Norie Murayama, Katsuhiro Tanaka, Shigeo Takenaka, F Peter Guengerich, Hiroshi Yamazaki, Masayuki Komori.   

Abstract

Several organoselenium compounds including benzyl selenocyanate (BSC), 1,2-phenylenebis(methylene)selenocyanate (o-XSC), 1,3-phenylenebis(methylene)selenocyanate (m-XSC), and 1,4-phenylenebis(methylene)selenocyanate (p-XSC) have been shown to prevent cancers caused by polycyclic aromatic hydrocarbons (PAHs) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in experimental animals; these chemical carcinogens are activated by human P450 1 and 2A family enzymes, respectively, to carcinogenic metabolites. In this study, we examined whether these selenium compounds interact with and inhibit human P450 1 and 2A enzymes in vitro. Four organoselenium compounds induced reverse Type I binding spectra with P450 1A1, 1A2, and 1B1 and Type I binding spectra with P450 2A6 and 2A13. The spectral dissociation constants (K(s)) for the interaction of P450 1B1 with these chemicals were 3.6-5.7 μM; the values were lower than those with seen with P450 1A1 (19-30 μM) or 1A2 (6.3-13 μM). The K(s) values for Type I binding of P450 2A13 with m-XSC and BSC were both 0.20 μM; the values were very low compared to those for the interaction of P450 2A6 with m-XSC (5.7 μM) and BSC (2.0 μM). Four selenium compounds directly inhibited 7-ethoxyresorufin O-deethylation activities catalyzed by P450 1A1, 1A2, and 1B1 with IC(50) values <1.0 μM, except for the inhibition of P450 1A2 by BSC (1.3 μM). Coumarin 7-hydroxylation activities of P450 2A13 were more inhibited by four selenium compounds than those of P450 2A6, with IC(50) values of 0.22-1.4 μM for P450 2A13 and 2.4-6.2 μM for P450 2A6. Molecular docking studies of the interaction of four organoselenium compounds with human P450 enzymes suggest that these chemicals can be docked into the active sites of these human P450 enzymes and that the sites of the selenocyanate functional groups of these chemicals differ between the P450 1 and 2A family enzymes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732699      PMCID: PMC3156385          DOI: 10.1021/tx200218u

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  54 in total

1.  Purification of cytochromes P450: products of bacterial recombinant expression systems.

Authors:  F P Guengerich; N A Hosea; M V Martin
Journal:  Methods Mol Biol       Date:  1998

2.  Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.

Authors:  Tsutomu Shimada; Katsuhiro Tanaka; Shigeo Takenaka; Norie Murayama; Martha V Martin; Maryam K Foroozesh; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

3.  Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.

Authors:  Hiroshi Yamazaki; Mami Nakamura; Tomoko Komatsu; Katsuhiro Ohyama; Naoya Hatanaka; Satoru Asahi; Noriaki Shimada; F Peter Guengerich; Tsutomu Shimada; Miki Nakajima; Tsuyoshi Yokoi
Journal:  Protein Expr Purif       Date:  2002-04       Impact factor: 1.650

4.  Comparative action of 1,4-phenylenebis(methylene)selenocyanate and its metabolites against 7,12-dimethylbenz[a]anthracene-DNA adduct formation in the rat and cell proliferation in rat mammary tumor cells.

Authors:  Karam El-Bayoumy; Arunangshu Das; Telih Boyiri; Dhimant Desai; Raghu Sinha; Brian Pittman; Shantu Amin
Journal:  Chem Biol Interact       Date:  2003-10-25       Impact factor: 5.192

5.  Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray.

Authors:  Karam El-Bayoumy; Bhagavathi A Narayanan; Dhimant H Desai; Narayanan K Narayanan; Brian Pittman; Shantu G Amin; Joel Schwartz; Daniel W Nixon
Journal:  Carcinogenesis       Date:  2003-07-04       Impact factor: 4.944

6.  Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.

Authors:  Haijian Wang; Wen Tan; Bingtao Hao; Xiaoping Miao; Gangqiao Zhou; Fuchu He; Dongxin Lin
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

7.  Covalent binding of polychlorinated biphenyls to proteins by reconstituted monooxygenase system containing cytochrome P-450.

Authors:  T Shimada; Y Imai; R Sato
Journal:  Chem Biol Interact       Date:  1981-12       Impact factor: 5.192

Review 8.  Mechanisms of mammary cancer chemoprevention by organoselenium compounds.

Authors:  Karam El-Bayoumy; Raghu Sinha
Journal:  Mutat Res       Date:  2004-07-13       Impact factor: 2.433

9.  Selective induction of two different molecular species of cytochrome P-450 by phenobarbital and 3-methylcholanthrene.

Authors:  N Harada; T Omura
Journal:  J Biochem       Date:  1981-01       Impact factor: 3.387

10.  Multiple forms of cytochrome P-450 purified from liver microsomes of phenobarbital- and 3-methylcholanthrene-pretreated rabbits. I. Resolution, purificaton, and molecular properties.

Authors:  Y Imai; C Hashimoto-Yutsudo; H Satake; A Girardin; R Sato
Journal:  J Biochem       Date:  1980-08       Impact factor: 3.387

View more
  13 in total

1.  Specificity determinants of CYP1B1 estradiol hydroxylation.

Authors:  Clinton R Nishida; Steven Everett; Paul R Ortiz de Montellano
Journal:  Mol Pharmacol       Date:  2013-07-02       Impact factor: 4.436

2.  Oxidation of Acenaphthene and Acenaphthylene by Human Cytochrome P450 Enzymes.

Authors:  Tsutomu Shimada; Shigeo Takenaka; Norie Murayama; Hiroshi Yamazaki; Joo-Hwan Kim; Donghak Kim; Francis K Yoshimoto; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2015-02-16       Impact factor: 3.739

3.  7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.

Authors:  Jiawang Liu; Thong T Nguyen; Patrick S Dupart; Jayalakshmi Sridhar; Xiaoyi Zhang; Naijue Zhu; Cheryl L Klein Stevens; Maryam Foroozesh
Journal:  Chem Res Toxicol       Date:  2012-04-10       Impact factor: 3.739

4.  Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.

Authors:  Tsutomu Shimada; Norie Murayama; Hiroshi Yamazaki; Katsuhiro Tanaka; Shigeo Takenaka; Masayuki Komori; Donghak Kim; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-03-13       Impact factor: 3.739

5.  Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition.

Authors:  Tsutomu Shimada; Donghak Kim; Norie Murayama; Katsuhiro Tanaka; Shigeo Takenaka; Leslie D Nagy; Lindsay M Folkman; Maryam K Foroozesh; Masayuki Komori; Hiroshi Yamazaki; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-03-13       Impact factor: 3.739

6.  Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2016-08-11       Impact factor: 3.739

7.  Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,2',5'-Tetrachlorobiphenyl.

Authors:  Tsutomu Shimada; Kensaku Kakimoto; Shigeo Takenaka; Nobuyuki Koga; Shotaro Uehara; Norie Murayama; Hiroshi Yamazaki; Donghak Kim; F Peter Guengerich; Masayuki Komori
Journal:  Drug Metab Dispos       Date:  2016-09-13       Impact factor: 3.922

8.  Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6.

Authors:  Tsutomu Shimada; Shigeo Takenaka; Kensaku Kakimoto; Norie Murayama; Young-Ran Lim; Donghak Kim; Maryam K Foroozesh; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2016-05-12       Impact factor: 3.739

9.  Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.

Authors:  Jiawang Liu; Shannon F Taylor; Patrick S Dupart; Corey L Arnold; Jayalakshmi Sridhar; Quan Jiang; Yuji Wang; Elena V Skripnikova; Ming Zhao; Maryam Foroozesh
Journal:  J Med Chem       Date:  2013-05-02       Impact factor: 7.446

10.  Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13.

Authors:  Tsutomu Shimada; Shigeo Takenaka; Norie Murayama; Valerie M Kramlinger; Joo-Hwan Kim; Donghak Kim; Jiawang Liu; Maryam K Foroozesh; Hiroshi Yamazaki; F Peter Guengerich; Masayuki Komori
Journal:  Xenobiotica       Date:  2015-08-06       Impact factor: 1.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.